AARD fundamentals
An in-depth look to Aardvark Therapeutics, Inc. operating, investing, and financing activities
AARD free cash flow for Q4 24 is -8.91 M USD. For 2024, AARD free cash flow was -19.39 M USD and operating cash flow was -19.28 M USD.
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '23
Q4 '23
Q3 '24
Q4 '24
TTM